Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncalmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity

PDE1A PDE1C

6.98e-053972GO:0048101
GeneOntologyMolecularFunctioncalmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity

PDE1A PDE1C

6.98e-053972GO:0004117
GeneOntologyMolecularFunctiontelomeric repeat-containing RNA binding

HNRNPA1L2 HNRNPA1

6.98e-053972GO:0061752
GeneOntologyMolecularFunctionRNA strand annealing activity

HNRNPA1L2 HNRNPA1

2.31e-045972GO:0033592
GeneOntologyCellularComponentnucleoplasmic periphery of the nuclear pore complex

HNRNPA1L2 HNRNPA1

3.09e-046962GO:1990826
GeneOntologyCellularComponentendocytic vesicle

ENTPD7 INPP5B RAPGEF1 PDIA3 AP2B1 PIK3C2B ATP6V0A4 TLR2

3.91e-04384968GO:0030139
GeneOntologyCellularComponentendocytic vesicle membrane

ENTPD7 INPP5B RAPGEF1 AP2B1 ATP6V0A4 TLR2

4.40e-04212966GO:0030666
GeneOntologyCellularComponentspliceosomal complex

DHX16 RBM3 HNRNPA1L2 HNRNPA1 HNRNPA1L3 PPIE

4.74e-04215966GO:0005681
GeneOntologyCellularComponentphagocytic vesicle membrane

INPP5B RAPGEF1 ATP6V0A4 TLR2

5.82e-0483964GO:0030670
GeneOntologyCellularComponentclathrin-sculpted glutamate transport vesicle membrane

OTOF RAB3A

7.36e-049962GO:0060203
GeneOntologyCellularComponentclathrin-sculpted glutamate transport vesicle

OTOF RAB3A

7.36e-049962GO:0060199
GeneOntologyCellularComponentphagocytic vesicle

INPP5B RAPGEF1 PDIA3 ATP6V0A4 TLR2

7.91e-04157965GO:0045335
GeneOntologyCellularComponentcatalytic step 2 spliceosome

HNRNPA1L2 HNRNPA1 HNRNPA1L3 PPIE

1.04e-0397964GO:0071013
Domain-

AP1B1 AP2B1

2.56e-0529522.60.40.1150
DomainClathrin_b-adaptin_app_Ig-like

AP1B1 AP2B1

2.56e-052952IPR013037
DomainHnRNPA1

HNRNPA1L2 HNRNPA1

7.65e-053952PF11627
DomainPDEase_N

PDE1A PDE1C

7.65e-053952IPR013706
DomainHnRNPA1

HNRNPA1L2 HNRNPA1

7.65e-053952IPR021662
DomainPDEase_I_N

PDE1A PDE1C

7.65e-053952PF08499
DomainAP_complex_bsu_1_2_4

AP1B1 AP2B1

7.65e-053952IPR016342
DomainB2-adapt-app_C

AP1B1 AP2B1

7.65e-053952PF09066
DomainB-adaptin_app_sub_C

AP1B1 AP2B1

1.53e-044952IPR015151
DomainB2-adapt-app_C

AP1B1 AP2B1

1.53e-044952SM01020
DomainAP_beta

AP1B1 AP2B1

2.53e-045952IPR026739
DomainBeta2_adaptin/TBP_C_dom

AP1B1 AP2B1

3.79e-046952IPR012295
Domain-

AP1B1 AP2B1

3.79e-0469523.30.310.10
DomainCoatomer/calthrin_app_sub_C

AP1B1 AP2B1

7.03e-048952IPR009028
DomainClathrin_a/b/g-adaptin_app_Ig

AP1B1 AP2B1

9.00e-049952IPR008152
DomainAlpha_adaptinC2

AP1B1 AP2B1

9.00e-049952PF02883
DomainAlpha_adaptinC2

AP1B1 AP2B1

9.00e-049952SM00809
DomainEF-hand_7

SPTAN1 KCNIP2 DST KCNIP4

9.28e-0485954PF13499
DomainARM

AP1B1 AP2B1 KPNA1

1.10e-0340953SM00185
DomainCoatomer/clathrin_app_Ig-like

AP1B1 AP2B1

1.63e-0312952IPR013041
DomainARM-type_fold

XPO4 PPP6R1 HUWE1 AP1B1 AP2B1 PIK3C2B KPNA1

1.72e-03339957IPR016024
DomainArmadillo

AP1B1 AP2B1 KPNA1

1.76e-0347953IPR000225
DomainRecoverin

KCNIP2 KCNIP4

1.93e-0313952IPR028846
DomainHelicase_C

DHX16 DDX60 DDX56 CHD2

2.17e-03107954PF00271
DomainHELICc

DHX16 DDX60 DDX56 CHD2

2.17e-03107954SM00490
DomainHelicase_C

DHX16 DDX60 DDX56 CHD2

2.25e-03108954IPR001650
DomainHELICASE_CTER

DHX16 DDX60 DDX56 CHD2

2.32e-03109954PS51194
DomainHELICASE_ATP_BIND_1

DHX16 DDX60 DDX56 CHD2

2.32e-03109954PS51192
DomainDEXDc

DHX16 DDX60 DDX56 CHD2

2.32e-03109954SM00487
DomainHelicase_ATP-bd

DHX16 DDX60 DDX56 CHD2

2.40e-03110954IPR014001
DomainClathrin/coatomer_adapt-like_N

AP1B1 AP2B1

2.57e-0315952IPR002553
DomainAdaptin_N

AP1B1 AP2B1

2.57e-0315952PF01602
DomainPDEase

PDE1A PDE1C

4.14e-0319952IPR023088
DomainPDEase_I

PDE1A PDE1C

5.05e-0321952PF00233
DomainPDEASE_I

PDE1A PDE1C

5.05e-0321952PS00126
DomainPDEase_CS

PDE1A PDE1C

5.05e-0321952IPR023174
Domain-

PDE1A PDE1C

5.53e-03229521.10.1300.10
DomainSpectrin

SPTAN1 DST

6.04e-0323952PF00435
DomainPDEase_catalytic_dom

PDE1A PDE1C

6.04e-0323952IPR002073
DomainDEAD/DEAH_box_helicase_dom

DHX16 DDX60 DDX56

6.13e-0373953IPR011545
DomainDEAD

DHX16 DDX60 DDX56

6.13e-0373953PF00270
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

MRPS31 RBM3 DDX60 SPTAN1 XPO4 GBE1 DDX56 PPP6R1 HUWE1 PDIA3 EVI5 DST AP2B1 HADHB HAX1 PBXIP1

3.03e-061440991630833792
Pubmed

Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.

ENTPD7 DDX60 XPO4 GBE1 CHD2 CMYA5 SEC22A EVI5 SCN9A PAN2 HADHB

4.25e-06686991129987050
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

MRPS31 KIAA0930 BEND3 ICE1 PPP6R1 HUWE1 AP2B1 WDR20 FBXW5 OSBPL9 PAN2 EIF2AK4 KPNA1

5.65e-061005991319615732
Pubmed

Post-translational modifications of hnRNP A1 differentially modulate retroviral IRES-mediated translation initiation.

HNRNPA1L2 HNRNPA1

8.02e-06299232960212
Pubmed

C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation.

C1QTNF9B C1QTNF9

8.02e-06299224030394
Pubmed

siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference.

HNRNPA1L2 HNRNPA1

8.02e-06299215215364
Pubmed

C1q and Tumor Necrosis Factor Related Protein 9 Protects from Diabetic Cardiomyopathy by Alleviating Cardiac Insulin Resistance and Inflammation.

C1QTNF9B C1QTNF9

8.02e-06299236766785
Pubmed

Hypermethylation of the CTRP9 promoter region promotes Hcy induced VSMC lipid deposition and foam cell formation via negatively regulating ER stress.

C1QTNF9B C1QTNF9

8.02e-06299237945738
Pubmed

Phosphorylation of hnRNP A1-Serine 199 Is Not Required for T Cell Differentiation and Function.

HNRNPA1L2 HNRNPA1

8.02e-06299238334757
Pubmed

CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism.

C1QTNF9B C1QTNF9

8.02e-06299222514273
Pubmed

Retroviral insertions downstream of the heterogeneous nuclear ribonucleoprotein A1 gene in erythroleukemia cells: evidence that A1 is not essential for cell growth.

HNRNPA1L2 HNRNPA1

8.02e-0629921406633
Pubmed

GCN2 regulates the CCAAT enhancer binding protein beta and hepatic gluconeogenesis.

CEBPB EIF2AK4

8.02e-06299223900421
Pubmed

CTRP 9 mitigates the apoptosis and unfolded protein response of OGD/R-induced retinal ganglion cells by regulating the AMPK pathway.

C1QTNF9B C1QTNF9

8.02e-06299238741428
Pubmed

C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform.

C1QTNF9B C1QTNF9

8.02e-06299225783894
Pubmed

Heterogeneous nuclear ribonucleoprotein A1 regulates rhythmic synthesis of mouse Nfil3 protein via IRES-mediated translation.

HNRNPA1L2 HNRNPA1

8.02e-06299228220845
Pubmed

C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway.

C1QTNF9B C1QTNF9

8.02e-06299221836066
Pubmed

Autoantibodies Against β1-Adrenoceptor Exaggerated Ventricular Remodeling by Inhibiting CTRP9 Expression.

C1QTNF9B C1QTNF9

8.02e-06299230764693
Pubmed

Effects of metal-binding properties of human Kv channel-interacting proteins on their molecular structure and binding with Kv4.2 channel.

KCNIP2 KCNIP4

8.02e-06299216951992
Pubmed

CTRP9 Regulates Growth, Differentiation, and Apoptosis in Human Keratinocytes through TGFβ1-p38-Dependent Pathway.

C1QTNF9B C1QTNF9

8.02e-06299229145717
Pubmed

Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice.

C1QTNF9B C1QTNF9

8.02e-06299224473438
Pubmed

Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation.

C1QTNF9B C1QTNF9

8.02e-06299222972916
Pubmed

Novel Pathological Role of hnRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) in Vascular Smooth Muscle Cell Function and Neointima Hyperplasia.

HNRNPA1L2 HNRNPA1

8.02e-06299228912364
Pubmed

Globular CTRP9 inhibits oxLDL-induced inflammatory response in RAW 264.7 macrophages via AMPK activation.

C1QTNF9B C1QTNF9

8.02e-06299227188183
Pubmed

hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis.

HNRNPA1L2 HNRNPA1

8.02e-06299236382566
Pubmed

Ablation of Ctrp9, Ligand of AdipoR1, and Lower Number of Cone Photoreceptors in Mouse Retina.

C1QTNF9B C1QTNF9

8.02e-06299235575905
Pubmed

Overexpression of CTRP9 attenuates the development of atherosclerosis in apolipoprotein E-deficient mice.

C1QTNF9B C1QTNF9

8.02e-06299230426302
Pubmed

CTRP9 ameliorates cellular senescence via PGC‑1α/AMPK signaling in mesenchymal stem cells.

C1QTNF9B C1QTNF9

8.02e-06299229749459
Pubmed

C1q/TNF-Related Protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress.

C1QTNF9B C1QTNF9

8.02e-06299226419929
Pubmed

CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages.

C1QTNF9B C1QTNF9

8.02e-06299231837806
Pubmed

C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways.

C1QTNF9B C1QTNF9

8.02e-06299228978553
Pubmed

Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein.

MAT2A MAF

8.02e-06299221362551
Pubmed

Association of C1q/TNF-Related Protein-9 (CTRP9) Level with Obstructive Sleep Apnea in Patients with Coronary Artery Disease.

C1QTNF9B C1QTNF9

8.02e-06299232831639
Pubmed

C1q/Tumor Necrosis Factor-Related Protein-9 Attenuates Diabetic Nephropathy and Kidney Fibrosis in db/db Mice.

C1QTNF9B C1QTNF9

8.02e-06299232283037
Pubmed

CTRP9 Promotes Brown Adipose Tissue Lipolysis in Mice Fed a High-Fat Diet.

C1QTNF9B C1QTNF9

8.02e-06299238940054
Pubmed

Loss of hnRNP A1 in murine skeletal muscle exacerbates high-fat diet-induced onset of insulin resistance and hepatic steatosis.

HNRNPA1L2 HNRNPA1

8.02e-06299231169879
Pubmed

C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure.

C1QTNF9B C1QTNF9

8.02e-06299227821723
Pubmed

Reduction of CTRP9, a novel anti-platelet adipokine, contributes to abnormal platelet activity in diabetic animals.

C1QTNF9B C1QTNF9

8.02e-06299226754066
Pubmed

Stage and cell-specific expression of calmodulin-dependent phosphodiesterases in mouse testis.

PDE1A PDE1C

8.02e-06299211369604
Pubmed

Regulation of mouse hepatitis virus RNA synthesis by heterogeneous nuclear ribonucleoprotein A1.

HNRNPA1L2 HNRNPA1

8.02e-06299211774503
Pubmed

Role of hnRNP A1 in coronavirus RNA synthesis.

HNRNPA1L2 HNRNPA1

8.02e-06299211774505
Pubmed

CTRP9 alleviates foam cells apoptosis by enhancing cholesterol efflux.

C1QTNF9B C1QTNF9

8.02e-06299233352225
Pubmed

The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo.

HNRNPA1L2 HNRNPA1

8.02e-0629928041722
Pubmed

C1q/tumour necrosis factor-related protein-9 aggravates lipopolysaccharide-induced inflammation via promoting NLRP3 inflammasome activation.

C1QTNF9B C1QTNF9

8.02e-06299235008006
Pubmed

Interplay between hnRNP A1 and a cis-acting element in the 3' UTR of CYP2A5 mRNA is central for high expression of the gene.

HNRNPA1L2 HNRNPA1

8.02e-06299212560094
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

MRPS31 RBM3 MAT2A SPTAN1 PPP6R1 HUWE1 HNRNPA1 PDIA3 AP1B1 AP2B1 PPIE HADHB HAX1 RIOK2 KPNA1

1.12e-051415991528515276
Pubmed

Network organization of the huntingtin proteomic interactome in mammalian brain.

PDE1A SPTAN1 HNRNPA1L2 HUWE1 HNRNPA1 DST AP1B1 AP2B1 HADHB RAB3A

1.15e-05621991022794259
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

DHX16 SPTAN1 PHRF1 BEND3 DDX56 CHD2 HUWE1 DST AP1B1 AP2B1

1.77e-05653991022586326
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

PHRF1 XPO4 ICE1 DST PAN2 SENP6 EIF2AK4 MAML2 CFAP97

2.10e-0552999914621295
Pubmed

CTRP9 knockout exaggerates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy through inhibiting the LKB1/AMPK pathway.

C1QTNF9B C1QTNF9

2.40e-05399231930700
Pubmed

Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q/TNF-related protein 9 genetic deficiency.

C1QTNF9B C1QTNF9

2.40e-05399235115674
Pubmed

Heterogeneous Nuclear Ribonucleoprotein A1 Improves the Intestinal Injury by Regulating Apoptosis Through Trefoil Factor 2 in Mice with Anti-CD3-induced Enteritis.

HNRNPA1L2 HNRNPA1

2.40e-05399225901972
Pubmed

Phosphomimetic substitution of heterogeneous nuclear ribonucleoprotein A1 at serine 199 abolishes AKT-dependent internal ribosome entry site-transacting factor (ITAF) function via effects on strand annealing and results in mammalian target of rapamycin complex 1 (mTORC1) inhibitor sensitivity.

HNRNPA1L2 HNRNPA1

2.40e-05399221454539
Pubmed

PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1.

HNRNPA1L2 HNRNPA1

2.40e-05399228115626
Pubmed

Multiple Kv channel-interacting proteins contain an N-terminal transmembrane domain that regulates Kv4 channel trafficking and gating.

KCNIP2 KCNIP4

2.40e-05399218957440
Pubmed

C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism.

C1QTNF9B C1QTNF9

2.40e-05399225870106
Pubmed

Adipocyte-Specific Hnrnpa1 Knockout Aggravates Obesity-Induced Metabolic Dysfunction via Upregulation of CCL2.

HNRNPA1L2 HNRNPA1

2.40e-05399238320300
Pubmed

HnRNP A1 Suppresses the Odontogenic Differentiation and the Inclusion of RUNX2 Exon 5 of Dental Mesenchymal Cells.

HNRNPA1L2 HNRNPA1

2.40e-05399237525910
Pubmed

The Gut Epithelial Receptor LRRC19 Promotes the Recruitment of Immune Cells and Gut Inflammation.

LRRC19 TLR2

2.40e-05399226776522
Pubmed

HuR-regulated mRNAs associated with nuclear hnRNP A1-RNP complexes.

HNRNPA1L2 HNRNPA1

2.40e-05399224152440
Pubmed

Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.

HNRNPA1L2 HNRNPA1

2.40e-05399215390079
Pubmed

HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis.

HNRNPA1L2 HNRNPA1

2.40e-05399233692334
Pubmed

Receptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B isoform of Ca2+/calmodulin-stimulated cAMP phosphodiesterase.

PDE1A PDE1C

2.40e-0539929003415
Pubmed

CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction.

C1QTNF9B C1QTNF9

2.40e-05399223842676
Pubmed

C1q/TNF-related protein-9 attenuates retinal inflammation and protects blood-retinal barrier in db/db mice.

C1QTNF9B C1QTNF9

2.40e-05399230978318
Pubmed

The Splicing Factor hnRNPA1 Regulates Alternate Splicing of the MYLK Gene.

HNRNPA1L2 HNRNPA1

2.40e-05399229077485
Pubmed

Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis.

C1QTNF9B C1QTNF9

2.40e-05399229925877
Pubmed

Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors.

HNRNPA1L2 HNRNPA1

2.40e-0539928912629
Pubmed

A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1.

HNRNPA1L2 HNRNPA1

2.40e-05399227151978
Pubmed

Resveratrol limits epithelial to mesenchymal transition through modulation of KHSRP/hnRNPA1-dependent alternative splicing in mammary gland cells.

HNRNPA1L2 HNRNPA1

2.40e-05399228088441
Pubmed

eIF2alpha phosphorylation tips the balance to apoptosis during osmotic stress.

HNRNPA1L2 HNRNPA1

2.40e-05399220338999
Pubmed

CTRP9 enhances carotid plaque stability by reducing pro-inflammatory cytokines in macrophages.

C1QTNF9B C1QTNF9

2.40e-05399225701788
Pubmed

Kinetic properties of Ca2+/calmodulin-dependent phosphodiesterase isoforms dictate intracellular cAMP dynamics in response to elevation of cytosolic Ca2+.

PDE1A PDE1C

2.40e-05399218335582
Pubmed

Quaking regulates Hnrnpa1 expression through its 3' UTR in oligodendrocyte precursor cells.

HNRNPA1L2 HNRNPA1

2.40e-05399221253564
Pubmed

Molecular cloning and characterization of a calmodulin-dependent phosphodiesterase enriched in olfactory sensory neurons.

PDE1A PDE1C

2.40e-0539927568196
Pubmed

LncRNAH19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1.

HNRNPA1L2 HNRNPA1

2.40e-05399233115498
Pubmed

hnRNP A1 and secondary structure coordinate alternative splicing of Mag.

HNRNPA1L2 HNRNPA1

2.40e-05399223704325
Pubmed

Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes.

PDE1A PDE1C

2.40e-05399217726023
Pubmed

Norovirus genome circularization and efficient replication are facilitated by binding of PCBP2 and hnRNP A1.

HNRNPA1L2 HNRNPA1

2.40e-05399223946460
Pubmed

Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.

MRPS31 MAT2A HNRNPA1L2 PPP6R1 HUWE1 HNRNPA1 PDIA3 AP1B1 AP2B1 PPIE HADHB HAX1 RIOK2 KPNA1

2.54e-051335991429229926
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

DHX16 RBM3 SPTAN1 DDX56 CHD2 PDIA3 AKAP9 AP1B1 AP2B1 TRPM1 EIF2AK4 HADHB HAX1 RIOK2

3.40e-051371991436244648
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

PDE1A INPP5B SPTAN1 SEC22A PITPNM1 FADS3 DST OSBPL9 PBXIP1

3.65e-0556899937774976
Pubmed

Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.

MRPS31 DHX16 RBM3 HNRNPA1L2 HNRNPA1 PDIA3 DST PPIE HADHB KPNA1

4.18e-05723991034133714
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

SPTAN1 XPO4 PPP6R1 HUWE1 PDIA3 MTMR11 AKAP9 WDR20 EIF2AK4 HADHB HAX1 KPNA1

4.42e-051049991227880917
Pubmed

Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.

HNRNPA1L2 HNRNPA1

4.79e-05499222345078
Pubmed

Differential distribution of KChIPs mRNAs in adult mouse brain.

KCNIP2 KCNIP4

4.79e-05499215363885
Pubmed

Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin.

C1QTNF9B C1QTNF9

4.79e-05499218787108
Pubmed

Irisin ameliorates endoplasmic reticulum stress and liver fibrosis through inhibiting PERK-mediated destabilization of HNRNPA1 in hepatic stellate cells.

HNRNPA1L2 HNRNPA1

4.79e-05499233951764
Pubmed

Role of activation of PIP5Kgamma661 by AP-2 complex in synaptic vesicle endocytosis.

AP1B1 AP2B1

4.79e-05499217290217
Pubmed

Structure, alternative splicing, and expression of the human and mouse KCNIP gene family.

KCNIP2 KCNIP4

4.79e-05499216112838
Pubmed

CTRP8 and CTRP9B are novel proteins that hetero-oligomerize with C1q/TNF family members.

C1QTNF9B C1QTNF9

4.79e-05499219666007
Pubmed

m6A-Induced lncRNA MEG3 Promotes Cerebral Ischemia-Reperfusion Injury Via Modulating Oxidative Stress and Mitochondrial Dysfunction by hnRNPA1/Sirt2 Axis.

HNRNPA1L2 HNRNPA1

4.79e-05499238358439
Pubmed

Specific effects of KChIP3/calsenilin/DREAM, but not KChIPs 1, 2 and 4, on calcium signalling and regulated secretion in PC12 cells.

KCNIP2 KCNIP4

4.79e-05499218393943
Pubmed

Analysis of RNA-protein interactions of mouse liver cytochrome P4502A5 mRNA.

HNRNPA1L2 HNRNPA1

4.79e-05499210215609
Pubmed

hnRNP Q and hnRNP A1 Regulate the Translation of Cofilin in Response to Transient Oxygen-Glucose Deprivation in Hippocampal Neurons.

HNRNPA1L2 HNRNPA1

4.79e-05499234944075
Pubmed

BCL-6 promotes the methylation of miR-34a by recruiting EZH2 and upregulating CTRP9 to protect ischemic myocardial injury.

C1QTNF9B C1QTNF9

4.79e-05499233502806
Pubmed

Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links.

ERCC4 SPTAN1

4.79e-05499212571280
Pubmed

C1q/Tumor Necrosis Factor-Related Protein-9 Is a Novel Vasculoprotective Cytokine That Restores High Glucose-Suppressed Endothelial Progenitor Cell Functions by Activating the Endothelial Nitric Oxide Synthase.

C1QTNF9B C1QTNF9

4.79e-05499238348774
Pubmed

Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.

HNRNPA1L2 HNRNPA1

4.79e-05499212426391
Pubmed

hnRNPA1 SUMOylation promotes cold hypersensitivity in chronic inflammatory pain by stabilizing TRPA1 mRNA.

HNRNPA1L2 HNRNPA1

4.79e-05499237943660
Pubmed

ATM binds to beta-adaptin in cytoplasmic vesicles.

AP1B1 AP2B1

4.79e-0549929707615
GeneFamilyPotassium voltage-gated channel regulatory subunits|DASH family

KCNIP2 KCNIP4

1.30e-0315652858
GeneFamilyExonucleases

EXO5 PAN2

1.48e-0316652544
GeneFamilyDNA helicases

CHD2 FBH1

1.67e-03176521167
GeneFamilyEndogenous ligands|C1q and TNF related

C1QTNF9B C1QTNF9

1.88e-03186521372
GeneFamilyPhosphodiesterases

PDE1A PDE1C

3.34e-0324652681
CoexpressionGRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP

CEBPB WASHC2C DDX60 HNRNPA1L2 HNRNPA1 DST AP2B1 TYW1B OTOF TLR2 LAMP3 RIOK2

2.95e-066169712MM977
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

HNRNPA1L2 GIMAP7 HNRNPA1 TESPA1 LAMP3 PBXIP1 CFAP97 MAF

1.08e-081909981634a6044dce4e026a63976031a498c7460e3dce
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

HNRNPA1L2 GIMAP7 HNRNPA1 TESPA1 LAMP3 PBXIP1 CFAP97 MAF

1.08e-0819099808813c2f9321b82f0ec66854bb7a383aa1171780
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

DDX60 GIMAP7 HNRNPA1 TESPA1 LAMP3 PBXIP1 CFAP97 MAF

1.17e-08192998e07b6892276c81c1227e94ca942f6820d89a7ca3
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class

DDX60 SPTAN1 GIMAP7 TESPA1 DST LAMP3 PBXIP1 MAF

1.60e-08200998d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

TMEM225B GIMAP7 TESPA1 TYW1B OTOF C1QTNF9 PBXIP1

7.77e-08162997af9999e5fcd28ff1f401d52fd220315752c40027
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

DDX60 SPTAN1 ICE1 TESPA1 LAMP3 PBXIP1 CFAP97

1.72e-071829971aea96ee211f7b9caef7fd385233f51be6021a73
ToppCellCOVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class

WASHC2C DDX60 ICE1 DST FBH1 LAMP3 CFAP97

1.72e-07182997877b6e611626628e709568747512f2827ebb2795
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DDX60 SPTAN1 ICE1 TESPA1 LAMP3 PBXIP1 CFAP97

1.72e-07182997b427e43ee523a3ea9eca3207f3d82042f10f022a
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DDX60 SPTAN1 ICE1 TESPA1 LAMP3 PBXIP1 CFAP97

1.72e-07182997c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DDX60 SPTAN1 ICE1 TESPA1 LAMP3 PBXIP1 CFAP97

1.72e-071829974cb182ef39be2044a6ad7266f332d4177591e550
ToppCellCOVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class

DDX60 SPTAN1 ICE1 TESPA1 LAMP3 PBXIP1 CFAP97

1.78e-071839977717fce227b4e02ed41baad8ae7dd2e22bd7c13e
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GIMAP7 HNRNPA1 TESPA1 LAMP3 PBXIP1 CFAP97 MAF

2.65e-071949970b0042b6a356a49a059fb64a1e1abb25c82d48cf
ToppCellCOVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

DDX60 SPTAN1 GIMAP7 TESPA1 DST PBXIP1 MAF

2.74e-0719599722191d361af136942508f1553ff41a626ed982ad
ToppCellBAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DDX60 GIMAP7 TESPA1 GRAP2 LAMP3 PBXIP1 MAF

2.94e-071979970b4fdf0131dd67a86ee3209fa66db0ca2e01a10e
ToppCellBAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DDX60 GIMAP7 TESPA1 GRAP2 LAMP3 PBXIP1 MAF

2.94e-07197997b3876076684781fb8384117f2cf367d828985986
ToppCellIPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class

PDE1C HEPACAM2 PRR23D2 ATP6V0A4 SCN9A NTN1

1.57e-06160996d65d19f4fae60836bfd4303a1bb7de34e9d83e35
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

DDX60 GIMAP7 TESPA1 LAMP3 PBXIP1 CFAP97

2.08e-061689965e721268f0baa51d3f640f7f4c41db769ebef210
ToppCellNS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PDE1A PDE1C HEPACAM2 DST ATP6V0A4 SCN9A

2.08e-061689966a233045638cb83dab64789b996b7598c325001e
ToppCellCOVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type

PDE1A PDE1C HEPACAM2 ATP6V0A4 KCNIP4 NTN1

2.73e-0617699645028197364c64e93e3ffe86aff773d47a477d49
ToppCellNS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PDE1A PDE1C HEPACAM2 DST ATP6V0A4 SCN9A

3.01e-0617999665a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPTAN1 GIMAP7 TESPA1 ATP6V0A4 PBXIP1 MAF

3.11e-06180996d9dae9db8e17f6990032ee6cfa8393fae4768ca5
ToppCellCOVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type

PDE1C HEPACAM2 ATP6V0A4 KCNIP4 NTN1 FHIP1A

3.31e-06182996ee6a8c356bbbdae55e4ea858337e079491f9f4aa
ToppCellfacs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRUNE2 PDE1C FADS3 DST PIK3C2B C1QTNF9

3.31e-06182996aa113a0d2c1d28bda24cbb1221afd21b5628dc6d
ToppCellcritical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

PDE1A PDE1C HEPACAM2 DST ATP6V0A4 SCN9A

3.52e-0618499658d36577eff814d46d72f031f3533d71549e3d6e
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DST NRK ATP6V0A4 KCNIP4 NTN1 FHIP1A

3.87e-06187996f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCellfacs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PDE1C RAPGEF1 FADS3 DST C1QTNF9 NTN1

3.87e-061879967170694a1b86fe8d84d96c880ffe57af09bdc026
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPTAN1 GIMAP7 TESPA1 GRAP2 PBXIP1 MAF

4.11e-061899969ab77c6fcb573854da5922412f53d2168bda6b58
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPTAN1 GIMAP7 TESPA1 GRAP2 PBXIP1 MAF

4.11e-061899965a9e2ca9a9ee2dc37ab9147a902115a9f1a80169
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

PDE1A FRAS1 SCN9A KCNIP4 NTN1 FHIP1A

4.11e-061899967659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

DDX60 GIMAP7 HNRNPA1 TESPA1 PBXIP1 CFAP97

4.24e-06190996f6616b3fe7f4962249503c96c06926240066d861
ToppCellPSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PDE1A PDE1C HEPACAM2 DST ATP6V0A4 SCN9A

4.37e-061919968f4637e801554e2343b974fe7794f01dd2151418
ToppCellfacs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRUNE2 PDE1C FADS3 DST C1QTNF9 NTN1

4.37e-061919966e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c
ToppCellfacs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRUNE2 PDE1C FADS3 DST C1QTNF9 NTN1

4.37e-06191996482db995930346be69072ace2fd78fd453e97fb5
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPTAN1 GIMAP7 TESPA1 MAML2 PBXIP1 MAF

4.64e-06193996194b49c152e3e3f599068ec88a7f0af6427b743a
ToppCellcritical-Lymphoid-Treg|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

GIMAP7 HNRNPA1 TESPA1 GRAP2 PBXIP1 MAF

4.78e-06194996deaae292972371b6afae58a023fe2fc05b351bda
ToppCellCOVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

SPTAN1 CHD2 GIMAP7 TESPA1 PBXIP1 MAF

4.92e-061959964bdedd924564a260841a9153604026b57487c83d
ToppCellBAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

GIMAP7 TESPA1 GRAP2 LAMP3 PBXIP1 MAF

4.92e-061959966ddce0cce14f737e45b8f57802c6a8ad07686262
ToppCellBAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

GIMAP7 TESPA1 GRAP2 LAMP3 PBXIP1 MAF

4.92e-06195996e6212373cc3c6c98f76e104e2ac1afa68965cc5f
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

GIMAP7 HNRNPA1 TESPA1 GRAP2 PBXIP1 CFAP97

4.92e-0619599653528e5788083bce5a8d4611ab3808878e6a9cd3
ToppCellCOVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type

PDE1A DST NRK TLR2 KCNIP4 FHIP1A

5.07e-0619699604f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCellMild_COVID-19-T/NK-CD4+_T_2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）

GIMAP7 TESPA1 GRAP2 LAMP3 PBXIP1 MAF

5.07e-06196996e50d03d8428dc4526e4607b6b4e99f0812a0ad31
ToppCellNS-critical-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

GIMAP7 HNRNPA1 TESPA1 GRAP2 PBXIP1 MAF

5.07e-06196996ad2d17cbfa1af4142f9cec2ea1a37d11d4b4151a
ToppCellNS-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

GIMAP7 HNRNPA1 TESPA1 GRAP2 PBXIP1 MAF

5.37e-06198996e2acb074142aa62c763139bbcf36f6f85038d04b
ToppCellBronchus_Control_(B.)-Epithelial-TX-Basal_1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

PDE1C HEPACAM2 DST ATP6V0A4 SCN9A NTN1

5.37e-06198996f632342e1e8911dd82b5df171776a84c7dc3f931
ToppCellBAL-Mild-Lymphocyte-T/NK-CD4+_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GIMAP7 TESPA1 GRAP2 LAMP3 PBXIP1 MAF

5.37e-061989966c375fc7e53ed7b7b0feba459958d177a65f7272
ToppCellControl-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class

DDX60 TESPA1 DNAJB13 LAMP3 PBXIP1 SLC29A4

5.37e-06198996ee71543559836fd59adc0da877b2ca538cba60cb
ToppCellBAL-Mild-Lymphocyte-T/NK-CD4+_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

GIMAP7 TESPA1 GRAP2 LAMP3 PBXIP1 MAF

5.53e-06199996ee29b65a3c545a9d19c2fbcc0364ee235dd018dc
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PDE1C HEPACAM2 ATP6V0A4 SCN9A NTN1

1.88e-05146995ec1f793409d1a81c0f9323eb3c82ffe01dae0e44
ToppCellIPF-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class

PDE1C HEPACAM2 PRR23D2 ATP6V0A4 MAF

2.75e-0515899567adf625a959444762d32268b3b7441f6f8b3b8c
ToppCelldroplet-Lung-nan-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CRYBG2 HEPACAM2 HNRNPA1 PIK3C2B SLC29A4

2.75e-0515899566c011e9de002224f70725dfe8e7871c8d304492
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CEBPB RAPGEF1 MTMR11 TLR2 GPCPD1

2.92e-051609956ed37d1fd0304932319d6b942502404115ff36a7
ToppCellIPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class

PDE1C HEPACAM2 ATP6V0A4 SCN9A NTN1

3.01e-05161995f1cd5c938cdc08ad8995371b72493850a6cf277a
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

DDX60 GIMAP7 ATP6V0A4 PBXIP1 MAF

3.19e-051639954dfd408aa700e307478ee35f6b902f68719d8d9e
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

GLS2 DDX56 HNRNPA1L3 TRPM1 RAB3A

3.19e-051639952d6fd2562d78be9f83fa35d811eb7e27eb8cc5d1
ToppCell3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

C1QTNF9B BEND3 CHD2 NRK MAML2

3.28e-05164995d167c7a987b9b35d1e7725c803df4f9cd5380e47
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE1A PDE1C ATP6V0A4 KCNIP4 NTN1

3.38e-051659959bd332e5ede759a00a47728ea5558c215efdd77a
ToppCellcontrol-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

PDE1C HEPACAM2 FADS3 ATP6V0A4 SCN9A

3.38e-051659955cfba9a46bd8ceeca74a6493057b4d38af6b06fe
ToppCellfacs-Heart-LA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CRYBG2 HEPACAM2 GIMAP7 TESPA1 TRPM1

3.58e-051679958ce8d93c79ac6a3f52252b4cec53378c362bfe0a
ToppCellfacs-Heart-LA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CRYBG2 HEPACAM2 GIMAP7 TESPA1 TRPM1

3.58e-051679958340f7075d00dccb304cfd4c9b5711ca6dbf7cce
ToppCellcontrol-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

PDE1C HEPACAM2 FADS3 ATP6V0A4 SCN9A

3.68e-05168995327b02f19f4a8607c033203824fdc60a1254331f
ToppCelldroplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ENTPD7 KIAA0930 GBE1 BEND3 PAN2

3.68e-05168995de1042267407719f19eb3f580a5df0c9cd0e8273
ToppCellBronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

PDE1C HEPACAM2 SALL1 SCN9A MAF

4.24e-05173995e1de849dcd96063136bdac87e050ddbd55cabdcc
ToppCellBronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

PDE1C HEPACAM2 SALL1 SCN9A MAF

4.24e-05173995f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06
ToppCellBAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PDE1A PDE1C HEPACAM2 ATP6V0A4 SCN9A

4.35e-05174995b7f5492ce8098f7eb0aef30ee558d00738d59d0e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE1C HEPACAM2 ATP6V0A4 NTN1 SLC29A4

4.35e-05174995d81a5e767e8882ebca4678af881c94c062f8cea5
ToppCellBAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

PDE1A PDE1C HEPACAM2 ATP6V0A4 SCN9A

4.35e-0517499571730503be3d9c839c4c9e950145e2101d682a1c
ToppCellBAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

PDE1A PDE1C HEPACAM2 ATP6V0A4 SCN9A

4.35e-05174995ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358
ToppCellBAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PDE1A PDE1C HEPACAM2 ATP6V0A4 SCN9A

4.35e-05174995cafe4d6b5f08d8888e9db6e196c66df991c03e7b
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE1A PDE1C HEPACAM2 ATP6V0A4 NTN1

4.35e-051749955f4436863a40f8bca46e2989bca66c02b6be88d4
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE1A PDE1C HEPACAM2 ATP6V0A4 NTN1

4.47e-0517599577c16e615c0fb9c83f29d7e0a547be72635fac81
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE1A PDE1C HEPACAM2 ATP6V0A4 NTN1

4.47e-0517599598947a226b5a2ac7091ff9d34243ea7736add973
ToppCellNS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PDE1C HEPACAM2 DST SCN9A MAF

4.47e-05175995a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PDE1A FRAS1 ERCC4 GBE1 KCNIP2

4.60e-0517699503d194c9814e12802cd932afade69e868814cb78
ToppCellNS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PDE1C HEPACAM2 DST ATP6V0A4 SCN9A

4.72e-0517799599500aed584f793aaf308f8afbf5d1c6a9b4ee55
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE1C HEPACAM2 OPHN1 ATP6V0A4 NTN1

4.72e-05177995f35b04c3557ebbdeba37dec54c8f45880eafb422
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE1C HEPACAM2 ATP6V0A4 NTN1 SLC29A4

4.85e-05178995f1cfc348d51362eb8c92c625f21f682afc0352b7
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PDE1A FRAS1 ERCC4 GBE1 KCNIP2

4.85e-05178995a62137d7f5fac16619f8a02844cdb0be7a794bf2
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

GIMAP7 TESPA1 GRAP2 MAML2 PBXIP1

4.85e-0517899531c847d7f7aa0f6d820afbb45d507992f5e9dc2f
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FRAS1 OPHN1 NRK ATP6V0A4 KCNIP4

4.98e-05179995666072c0e8448dbaec1683d18368ec2502453f90
ToppCellNS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PDE1C HEPACAM2 DST ATP6V0A4 SCN9A

5.12e-051809958af8b4af2dc72223ac71fc027e0d4280c5dd81f8
ToppCell5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDE1C HEPACAM2 SALL1 ATP6V0A4 SCN9A

5.12e-051809955286e66ff6b7154390b3e9c189704a71d56bc89c
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

GIMAP7 TESPA1 ATP6V0A4 PBXIP1 MAF

5.12e-05180995f3d35b2ea78afef37a84232adf5e6e26712b618d
ToppCell5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDE1C HEPACAM2 SALL1 ATP6V0A4 SCN9A

5.12e-051809952b6b295b5c21b829828afae9ab4c3eb9233f6f45
ToppCell5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDE1C HEPACAM2 SALL1 ATP6V0A4 SCN9A

5.12e-05180995bf587387145a2b5e83766fbccf76eecc6d5e8241
ToppCellCOVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class

PDE1A PDE1C HEPACAM2 ATP6V0A4 MAF

5.25e-051819954a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4
ToppCellRV|World / Chamber and Cluster_Paper

PDE1A PDE1C CMYA5 AKAP9 HADHB

5.25e-05181995bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCelldroplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRUNE2 PDE1C FADS3 C1QTNF9 NTN1

5.39e-05182995c7f2d24697affa530b748ab32b1d40bdc1bdc20a
ToppCelldroplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRUNE2 PDE1C FADS3 C1QTNF9 NTN1

5.39e-05182995d95635b74e8cd8bc00bfe40340806b59fb9bee43
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

DDX60 GIMAP7 HNRNPA1 TESPA1 CFAP97

5.39e-051829953a3ed195c15d33d46a2f395cb93018e4bba28353
ToppCellNS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PDE1A PDE1C HEPACAM2 DST SCN9A

5.53e-05183995ba43bca2b45be1008eebd3f033cecb061fb3a966
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LCA5 PDE1A GBE1 TESPA1 KCNIP4

5.53e-0518399501ad18f198195ce341bae01a1c8c253cc4607766
ToppCellCOVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class

WASHC2C ICE1 FBH1 CPLANE1 CFAP97

5.53e-0518399522bd05135906d0ecc4ba8c2e0a666093d1bf3b8f
ToppCellCOVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type

PDE1A PDE1C HEPACAM2 ATP6V0A4 NTN1

5.53e-051839955c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE1C FRAS1 NRK SCN9A CSMD1

5.68e-051849952cbed6462fea2622871bb7e49b0df3d984239281
ToppCelldroplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRUNE2 PDE1C FADS3 C1QTNF9 NTN1

5.68e-05184995087666ba949b129c53d7ace40f9e543e3875a7de
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE1C FRAS1 NRK SCN9A CSMD1

5.68e-05184995ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE1C FRAS1 NRK SCN9A CSMD1

5.68e-051849952b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDE1C HEPACAM2 SALL1 ATP6V0A4 SLC29A4

5.68e-0518499592314fcdb74c0a1262c9334c774819a2a49ba454
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

DDX60 GIMAP7 TESPA1 LAMP3 PBXIP1

5.82e-05185995406b52516b26e9fe2c9e768950af447ec7ad5f3e
ToppCellBrain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.

ICE1 HNRNPA1L2 AKAP9 AP2B1 CFAP97

5.82e-05185995857c7ca8493e91ef1d0078ddafd6082020f9b169
Diseaselipid metabolism disorder (implicated_via_orthology)

MAT2A FADS3 HADHB

1.43e-0515953DOID:3146 (implicated_via_orthology)
Diseaseskin disease (implicated_via_orthology)

C1QTNF9B C1QTNF9

3.07e-053952DOID:37 (implicated_via_orthology)
Diseasesleep latency

FRAS1 ERCC4 CSMD1

2.32e-0437953EFO_0005280
Diseasecleft lip

RAPGEF1 ICE1 HNRNPA1L3 DST NTN1 CSMD1

3.20e-04284956EFO_0003959
Diseaseresponse to lamotrigine

PDE1C CSMD1

3.64e-049952EFO_0007661
Diseasepostburn hypertrophic scarring severity measurement

KCNIP4 CSMD1

4.54e-0410952EFO_0007747
Diseasemyopathy (implicated_via_orthology)

HNRNPA1L2 HNRNPA1 HNRNPA1L3

5.03e-0448953DOID:423 (implicated_via_orthology)
Diseasecannabis dependence measurement

SCN9A CSMD1 PMM1

5.03e-0448953EFO_0008457
DiseaseMyoclonic Astatic Epilepsy

CHD2 SCN9A

5.54e-0411952C0393702
Diseasecutaneous Leishmaniasis

PPP6R1 LAMP3

1.20e-0316952EFO_0005046
Diseaseneurodegenerative disease (implicated_via_orthology)

HNRNPA1L2 HNRNPA1 HNRNPA1L3 MTMR11

1.26e-03145954DOID:1289 (implicated_via_orthology)
Diseaseemphysema imaging measurement

ERCC4 LRRC19 CSMD1 RAB3A

1.29e-03146954EFO_0007626
Diseasewellbeing measurement, alcohol consumption measurement

CMYA5 DST NTN1

1.78e-0374953EFO_0007869, EFO_0007878
Diseasenicotine dependence

PDE1C ICE1 HAX1

2.07e-0378953EFO_0003768
Diseaseglomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement

CHRNA9 CSMD1

2.27e-0322952EFO_0005199, EFO_0005208, EFO_0007892
Diseasenighttime rest measurement

PDE1A CSMD1

2.70e-0324952EFO_0007827
Diseasealpha-linolenic acid measurement

FADS3 CSMD1

2.93e-0325952EFO_0007759
Diseaseantiphospholipid antibody measurement

LCA5 PDE1C

2.93e-0325952EFO_0005200
Diseasecerebellum cortex volume change measurement, age at assessment

MAML2 CSMD1

3.17e-0326952EFO_0008007, EFO_0021497

Protein segments in the cluster

PeptideGeneStartEntry
FDGDAVLFSDESEHF

NT5C1B

466

Q96P26
TELFHSNEESGFFNE

AKAP9

2676

Q99996
NADELLESFLEGFHD

AP2B1

461

P63010
DILEGEVDHSFFDSD

CFAP97

6

Q9P2B7
EVDHSFFDSDFEEGK

CFAP97

11

Q9P2B7
QLSFHTFALEEDFDI

CSMD1

71

Q96PZ7
DDEDEHGGVFSQSFL

EIF2AK4

736

Q9P2K8
FNALDSGDLSDFIED

CHRNA9

186

Q9UGM1
NADELLESFLEGFHD

AP1B1

461

Q10567
ADEEFLFGDVELSRH

DHX16

251

O60231
NDIDAFEFHEAFSGQ

HADHB

371

P55084
FSRLHTFGDENEDDS

NTN1

251

O95631
RGFAFVTFDDHDSVD

HNRNPA1L2

146

Q32P51
RGFAFVTFDDHDSVD

HNRNPA1L3

101

A0A2R8Y4L2
NTDEQALEDHFSSFG

RBM3

16

P98179
RQLADHLGFEFFEAS

RAB3A

151

P20336
SFQFDFIGDTLTDDE

OPHN1

66

O60890
SEDEFYDADEFHQSG

OSBPL9

291

Q96SU4
SFFEAEQVDPGHFLD

BEND3

356

Q5T5X7
GFSDLSDSEFLEFLD

EXO5

16

Q9H790
EFDAFSGSLSDFDVH

PAN2

231

Q504Q3
PLSFHHFFATDDDDN

FRAS1

1851

Q86XX4
HFFATDDDDNLQRDA

FRAS1

1856

Q86XX4
HDNFGFDDLVRDFNS

HAX1

76

O00165
AAGGLHFDDRFSDEQ

MAF

251

O75444
NFVLGRFDHEDESDA

ENTPD7

226

Q9NQZ7
DFEFSEFFLLALHDS

MTMR11

451

A4FU01
FYDTPLFEDDDHDSL

DST

2401

Q03001
NGFHEAFIEEGTFLF

MAT2A

6

P31153
LGDDSFLERFNTHYD

EDEM3

306

Q9BZQ6
FFREDDGGADLHNAT

KIAA0930

331

Q6ICG6
DEADLLFSFGFEEEL

DDX56

166

Q9NY93
NDFVESEFFLIDGDS

DDX60

31

Q8IY21
RGSDAFFDALDHVID

FBXW5

386

Q969U6
SFDVFALNEASGEHS

PDE1A

161

P54750
FDVFSLNEASGDHAL

PDE1C

171

Q14123
LIGDDESFHSSDEDF

EVI5

731

O60447
ESFHSSDEDFIDNSL

EVI5

736

O60447
AFDTDHNGAVSFEDF

KCNIP4

131

Q6PIL6
AFDTNHDGSVSFEDF

KCNIP2

151

Q9NS61
EAGHVFDDFSSDAVF

PHRF1

1266

Q9P1Y6
FDDFSSDAVFIQLDD

PHRF1

1271

Q9P1Y6
SRDQEHDEDEGFFLS

LCA5

646

Q86VQ0
HDEDEGFFLSEGRSF

LCA5

651

Q86VQ0
QAFDFEDDHFGNVDE

LAMP3

361

Q9UQV4
DFEEFTGHVDRIFED

GLS2

156

Q9UI32
DELLDDFFHDQSTAT

HUWE1

2621

Q7Z6Z7
YHNEVDAFLLADGDF

PIK3C2B

511

O00750
AFQGTDHSSDLAFDF

MAML2

1096

Q8IZL2
FNGLFADEDDDTTFT

C1QTNF9

311

P0C862
ADEDDDTTFTGFLLF

C1QTNF9

316

P0C862
LFDDSFLHAAFHEGS

ASPHD2

321

Q6ICH7
ELFFHTSEDQGAANF

FHIP1A

181

Q05DH4
QRLDHSTDFFSEAFE

GBE1

661

Q04446
ENFFASADEELTIDH

FBH1

561

Q8NFZ0
STEFVDHDHFFDEDL

ICE1

316

Q9Y2F5
FDFFEEDLSEHVVQG

GPCPD1

231

Q9NPB8
FQDFEAEETNEGRHF

CPLANE1

506

Q9H799
DHFNADGSEDFCFLL

CHD2

851

O14647
SGQHHDFLSDLFSDD

CEBPB

111

P17676
ESFEHISENEFASEA

CMYA5

3456

Q8N3K9
FLGDHFSFEDDQAAL

CRYBG2

1366

Q8N1P7
FNGLFADEDDDTTFT

C1QTNF9B

311

B2RNN3
ADEDDDTTFTGFLLF

C1QTNF9B

316

B2RNN3
SEFFDAEGSEVDLNF

DNAJB13

111

P59910
FQELDLSKEAFFFHD

INPP5B

381

P32019
AQTFSGHEDALDDFG

HEPACAM2

396

A8MVW5
DFEALEDDELGFHSG

GRAP2

281

O75791
GAEDATDAFRAFHQD

FADS3

66

Q9Y5Q0
HRGFAFVEFELAEDA

PPIE

46

Q9UNP9
FHAIESLLQSDGDDF

SEC22A

211

Q96IW7
GSFDEKNFDDLDNFS

SALL1

811

Q9NSC2
IFEQLHSFVVDDDGF

LRRC19

341

Q9H756
DHFSADDFLGAIELD

OTOF

1836

Q9HC10
SVDDFSLEFHAQDGD

PRR23D1

141

E9PI22
TFEDTYDHANGNDDL

NRK

941

Q7Z2Y5
FDDDGSEFHEHIFLE

MRPS31

321

Q92665
EAAFDHSFSDASGLN

PRUNE2

2296

Q8WUY3
TNEESHEVFFSGLFE

TMEM225B

41

P0DP42
AFDLIEHYFGTEDED

KPNA1

496

P52294
IVGFFDDSFSEAHSE

PDIA3

156

P30101
ELEGQSFHDFIADAD

GIMAP7

136

Q8NHV1
SETEFADDEHSIFGD

SCN9A

566

Q15858
EFSGSDEDFQDLLHF

WDR20

326

Q8TBZ3
DQDSFDTIHFFGNET

PMM1

206

Q92871
SVDDFSLEFHAQDGD

PRR23D2

141

P0DMB1
SEEEFFDAHEGFSDS

PITPNM1

346

O00562
DEEHVFDAFDASFKD

ZFP41

56

Q8N8Y5
FIDFSDTDEVFRGHE

XPO4

926

Q9C0E2
VDDFEDFIFSHFFGD

PBXIP1

681

Q96AQ6
DDIINFFNDFSDHLA

RAPGEF1

1036

Q13905
DSFHLQQFFRDSDEL

SPTAN1

571

Q13813
FQFFDEEEETGENHT

SENP6

631

Q9GZR1
HSRGEADLFDSGDIF

WASHC2C

1101

Q9Y4E1
HGDFNEFNLILDESD

RIOK2

226

Q9BVS4
IDHFGFNDEEFGEQE

PPP6R1

566

Q9UPN7
HFNGEELLFEDTSLS

TRPM1

1276

Q7Z4N2
ALDDHGEEFNFGDVF

ATP6V0A4

706

Q9HBG4
NFNFDHPDAFDFDLI

UCKL1

151

Q9NWZ5
FTFDSHQLEEAAEAA

SLC29A4

26

Q7RTT9
AEDVLFSLGFGQEDH

TESPA1

161

A2RU30
HEEFDVNLSSDAAFG

ERCC4

531

Q92889
RGFAFVTFDDHDSVD

HNRNPA1

146

P09651
ELDFSHFRLFDENND

TLR2

716

O60603
FESSSEEEFGGEDHQ

TYW1B

246

Q6NUM6
FGADADFVVLDDSLH

AMDHD2

376

Q9Y303